by Lyme Disease Diagnostic Devices Market size is expected to grow Usd 3.87 bn by 2027 at a CAGR of 7.2% over the forecast period 2020 – 2027.
A new study on the global Lyme Disease Diagnostic Devices market has been published by Precedence Research. It presents a wealth of information on key market dynamics, including the drivers, market trends, and challenges, as well as the structure of the global Lyme Disease Diagnostic Devices market. The study offers valuable information about the global Lyme Disease Diagnostic Devices market to illustrate how the market would grow during the forecast period 2020-2027. The report provides the value and volume of the global Lyme Disease Diagnostic Devices market for the period 2020–2027, considering 2019 as the base year and 2027 as the forecast year. The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study.
Key indicators of market growth, which include value chain as well as supply chain analyses, and Compound Annual Growth Rate (CAGR), are elucidated in the study in a comprehensive manner. This data can help readers interpret quantitative growth aspects of the global Lyme Disease Diagnostic Devices market during the forecast period.
Get the Sample Pages of Report@ https://www.precedenceresearch.com/sample/1183
An extensive analysis on business strategies of leading market players is also featured in study on the global Lyme Disease Diagnostic Devices market. This can help readers understand principal factors to foresee growth in the global Lyme Disease Diagnostic Devices market. In this study, readers can also find specific data on the qualitative and quantitative growth avenues for the global market, which is expected to guide market players in making apt decisions in the future.
The report also delves into the competition landscape of the global Lyme Disease Diagnostic Devices market. Key players operating in the global market have been identified, and each one of these has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global market report.
Key Players
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific, Inc.
- Boulder Diagnostics
- T2 Biosystems, Inc.
- Abbott
- Oxford Immunotec Global PLC
- Quidel Corporation
- Affymetrix Inc.
- Hoffmann-La Roche Ltd
- Graphene Frontiers
Key Questions Answered in Lyme Disease Diagnostic Devices Market Study
– What are the key factors influencing the Lyme Disease Diagnostic Devices market in each region?
– What will be the CAGR of the global Lyme Disease Diagnostic Devices market between 2016 and 2027?
– What is the future scope and changing trends in technologies in the global Lyme Disease Diagnostic Devices market?
– Which factors will impede the growth of the global Lyme Disease Diagnostic Devices market during the forecast period?
– Which are the leading companies in the global Lyme Disease Diagnostic Devices market?
– Which region is set to expand at the fastest CAGR during the forecast period?
– What is the volume (Units) of different Lyme Disease Diagnostic Devices across all regions during the forecast period?
– Which segment will have the highest revenue globally in 2027 and which segment will expand at the fastest CAGR during the forecast period?
Get Customization on this Research Report@ https://www.precedenceresearch.com/customization/1183
Research Methodology
A unique research methodology has been utilized by precedence research to conduct a comprehensive research on the growth of the global Lyme Disease Diagnostic Devices market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary sources referred to by analysts during the production of the global Lyme Disease Diagnostic Devices market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of our study on the market as a primary source.
These primary and secondary sources provided exclusive information during interviews, which serves as a validation from Lyme Disease Diagnostic Devices industry leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped in making precedence research estimates on the future prospects of the global market more reliable and accurate.
Segmentation
By Product Type
- Serological Test
- Urine Antigen Tests
- Lymphocytic Transformation Test
- Immunofluorescent Staining
- Nucleic acid Test
By End User
- Hospitals
- Public/Private Laboratories
- Physician’s Office
By Geography
-
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- United Kingdom
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of Middle East & Africa
- North America
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. DataSources
2.3. Assumptions& Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Lyme End User Diagnostic Devices Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
Chapter 5. COVID 19 Impact on Lyme End User Diagnostic Devices Market
5.1. Covid-19: Lyme End User Diagnostic Devices Industry Impact
5.2. Lyme End User Diagnostic Devices Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Lyme End User Diagnostic Devices Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Lyme End User Diagnostic Devices Market Players to deal with Covid-19 Pandemic Scenario
Chapter 6. Lyme End User Diagnostic Devices Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Growing prevalence of Lyme disease
6.1.1.2. Growing investment in research and development
6.1.2. Market Restraints
6.1.2.1. Lack of awareness
6.1.3. Market Opportunities
6.1.3.1. Technological advancements
Chapter 7. Global Lyme End User Diagnostic Devices Market: Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Lyme End User Diagnostic Devices Market Revenue by Market Players (2016 -2019)
7.1.1.2. Lyme End User Diagnostic Devices Market Revenue Market Share by Market Players (2016 -2019)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Type Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users
Chapter 8. Global Lyme End User Diagnostic Devices Market, By Product Type
8.1. Lyme End User Diagnostic Devices Market, by Product Type, 2016-2027
8.1.1. Serological Test
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Urine Antigen Tests
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Lymphocytic Transformation Test
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Immunofluorescent Staining
8.1.4.1. Market Revenue and Forecast (2016-2027)
8.1.5. Nucleic Acid Test
8.1.5.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Lyme End User Diagnostic Devices Market, By End User
9.1. Lyme End User Diagnostic Devices Market, by End User, 2016-2027
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Public/Private Laboratories
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Physician’s Office
9.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 10. Global Lyme End User Diagnostic Devices Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue Forecast by Product Type(2016-2027)
10.1.2. Market Revenue Forecast by End User (2016-2027)
10.1.3. U.S
10.1.3.1. Market Revenue Forecast (2016-2027)
10.1.4. Canada
10.1.4.1. Market Revenue Forecast (2016-2027)
10.2. Europe
10.2.1. Market Revenue Forecast by Product Type (2016-2027)
10.2.2. Market Revenue Forecast by End User (2016-2027)
10.2.3. UK
10.2.3.1. Market Revenue Forecast (2016-2027)
10.2.4. Germany
10.2.4.1. Market Revenue Forecast (2016-2027)
10.2.5. France
10.2.5.1. Market Revenue Forecast (2016-2027)
10.2.6. Rest of EU
10.2.6.1. Market Revenue Forecast (2016-2027)
10.3. Asia Pacific (APAC)
10.3.1. Market Revenue Forecast by Product Type (2016-2027)
10.3.2. Market Revenue Forecast by End User (2016-2027)
10.3.3. China
10.3.3.1. Market Revenue Forecast (2016-2027)
10.3.4. India
10.3.4.1. Market Revenue Forecast (2016-2027)
10.3.5. Japan
10.3.5.1. Market Revenue Forecast (2016-2027)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue Forecast (2016-2027)
10.4. LATAM
10.4.1. Market Revenue Forecast by Product Type (2016-2027)
10.4.2. Market Revenue Forecast by End User (2016-2027)
10.4.3. Brazil
10.4.3.1. Market Revenue Forecast (2016-2027)
10.4.4. Rest of LATAM
10.4.4.1. Market Revenue Forecast (2016-2027)
10.5. Middle East and Africa (MEA)
10.5.1. Market Revenue Forecast by Product Type (2016-2027)
10.5.2. Market Revenue Forecast by End User (2016-2027)
10.5.3. GCC
10.5.3.1. Market Revenue Forecast (2016-2027)
10.5.4. North Africa
10.5.4.1. Market Revenue Forecast (2016-2027)
10.5.5. South Africa
10.5.5.1. Market Revenue Forecast (2016-2027)
10.5.6. Rest of MEA
10.5.6.1. Market Revenue Forecast (2016-2027)
Chapter 11. Company Profiles
11.1. Bio-Rad Laboratories, Inc.
11.1.1. Company Overview, Business Information, Regional Presence
11.1.2. Product Portfolio Analysis
11.1.2.1. Product Details, Specification, End User
11.1.3. Revenue, Price, and Gross Margin (2015-2020)
11.1.4. Recent Developments and Strategies
11.2. Thermo Fisher Scientific, Inc.
11.2.1. Company Overview, Business Information, Regional Presence
11.2.2. Product Portfolio Analysis
11.2.2.1. Product Details, Specification, End User
11.2.3. Revenue, Price, and Gross Margin (2015-2020)
11.2.4. Recent Developments and Strategies
11.3. Boulder Diagnostics
11.3.1. Company Overview, Business Information, Regional Presence
11.3.2. Product Portfolio Analysis
11.3.2.1. Product Details, Specification, End User
11.3.3. Revenue, Price, and Gross Margin (2015-2020)
11.3.4. Recent Developments and Strategies
11.4. T2 Biosystems, Inc.
11.4.1. Company Overview, Business Information, Regional Presence
11.4.2. Product Portfolio Analysis
11.4.2.1. Product Details, Specification, End User
11.4.3. Revenue, Price, and Gross Margin (2015-2020)
11.4.4. Recent Developments and Strategies
11.5. Abbott
11.5.1. Company Overview, Business Information, Regional Presence
11.5.2. Product Portfolio Analysis
11.5.2.1. Product Details, Specification, End User
11.5.3. Revenue, Price, and Gross Margin (2015-2020)
11.5.4. Recent Developments and Strategies
11.6. Oxford Immunotec Global PLC
11.6.1. Company Overview, Business Information, Regional Presence
11.6.2. Product Portfolio Analysis
11.6.2.1. Product Details, Specification, End User
11.6.3. Revenue, Price, and Gross Margin (2015-2020)
11.6.4. Recent Developments and Strategies
11.7. Quidel Corporation
11.7.1. Company Overview, Business Information, Regional Presence
11.7.2. Product Portfolio Analysis
11.7.2.1. Product Details, Specification, End User
11.7.3. Revenue, Price, and Gross Margin (2015-2020)
11.7.4. Recent Developments and Strategies
11.8. Affymetrix Inc.
11.8.1. Company Overview, Business Information, Regional Presence
11.8.2. Product Portfolio Analysis
11.8.2.1. Product Details, Specification, End User
11.8.3. Revenue, Price, and Gross Margin (2015-2020)
11.8.4. Recent Developments and Strategies
11.9. F. Hoffmann-La Roche Ltd
11.9.1. Company Overview, Business Information, Regional Presence
11.9.2. Product Portfolio Analysis
11.9.2.1. Product Details, Specification, End User
11.9.3. Revenue, Price, and Gross Margin (2015-2020)
11.9.4. Recent Developments and Strategies
11.10. Graphene Frontiers
11.10.1. Company Overview, Business Information, Regional Presence
11.10.2. Product Portfolio Analysis
11.10.2.1. Product Details, Specification, End User
11.10.3. Revenue, Price, and Gross Margin (2015-2020)
11.10.4. Recent Developments and Strategies
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
Get Full Access of this Research Report, Click here@ https://www.precedenceresearch.com/checkout/1183
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
